首页|Change of Cytokines in Chronic Hepatitis B Patients and HBeAg are Positively Correlated with HBV RNA, Based on Real-world Study

Change of Cytokines in Chronic Hepatitis B Patients and HBeAg are Positively Correlated with HBV RNA, Based on Real-world Study

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
  • 维普
Background and Aims: The natural course of chronic hep-atitis B virus (HBV) infection is widely studied; however, follow-up studies of the same patients are scanty. Here, we studied the dynamic changes of serum HBV RNA and cytokines in hepatitis B virus e antigen (HBeAg)-positive patients treated with entecavir (ETV) to explore the rela-tionship between the HBV serum viral nucleic acids and host immunity. Methods: Thirty-three chronic hepatitis B patients who are HBeAg-positive, with high virus load (HBV DNA >20,000 IU/mL), and received standard nucleos(t) ide analogue (NA) antiviral therapy (ETV) for more than 48 weeks were included. The serum levels of HBV nucleic acids and selected cytokines were measured at 0, 12, 24, and 48 weeks respectively. Results: Serum HBV RNA could still be detected while serum HBV DNA had fallen below the detection limit in patients treated with ETV. There was a strong positive correlation between HBV RNA and HBeAg, with a concomitant decrease in the secretion of cytokines from type 1 helper T (Th1)/type 2 helper T (Th2)/interleu-kin (IL)-17 producing T (Th17) cells. IL-4 and IL-10 were the main cytokines negatively associated with serum HBV RNA. Conclusions: HBeAg can be used to reflect the load of HBV RNA indirectly, because serum HBV RNA has not been widely used in clinical practice. Meanwhile, serum IL-4 and IL-10 might be explored in combination with HBV RNA in guiding future clinical antiviral therapy.

HBV RNACytokinesHBeAg positiveEntecavirChronic hepatitis B

Qiqi Zhang、Hui Huang、Aijun Sun、Chunyan Liu、Zhidong Wang、Feifan Shi、Wei Duan、Xueying Sun、Qi Wang、Ping Sun、Chunwen Pu、Yong Zhang

展开 >

Department of Biobank,The Sixth Affiliated People's Hospital of Dalian Medical University,Dalian,Liaoning,China

Out-patient Department of Hepatitis,The Sixth Affiliated People's Hospital of Dalian Medical University,Dalian,Liaoning,China

Department of Pathology,The Sixth Affiliated People's Hospital of Dalian Medical University,Dalian,Liaoning,China

School of Pharmacy,Shenyang Pharmaceutical University,Shenyang,Liaoning,China

School of Medicine,Deakin Univer-sity,Victoria,Australia

展开 >

Dalian Med-ical Science Research ProgramNatural Science Foundation of Liaoning Province

19110432019-ZD-1003

2022

10.14218/JCTH.2021.00160

临床与转化肝病杂志(英文版)

临床与转化肝病杂志(英文版)

ISSN：
年,卷(期)：2022.10(3)
  • 3